We are live on ! Find out more
LAB icon

Standard BioTools
LAB

119 hedge funds and large institutions have $387M invested in Standard BioTools in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 39 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

202% more call options, than puts

Call options by funds: $4.08M | Put options by funds: $1.35M

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

9% more capital invested

Capital invested by funds: $354M → $387M (+$32.4M)

5% more funds holding

Funds holding: 113 → 119 (+6)

0.16% more ownership

Funds ownership: 76.82% → 76.98% (+0.16%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

18% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 39

Holders
119
Holders Change
+6
Holders Change %
+5.31%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
32
Reduced
39
Closed
12
Calls
$4.08M
Puts
$1.35M
Net Calls
+$2.73M
Net Calls Change
+$2.2M

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.63M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$2.1M
3
N
Nuveen
North Carolina
+$1.92M
4
SAM
Silverback Asset Management
North Carolina
+$1.88M
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$1.53M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$3.49M
2
CS
Candriam SCA
Luxembourg
-$1.07M
3
HSA
Hussman Strategic Advisors
Maryland
-$887K
4
Jennison Associates
Jennison Associates
New York
-$830K
5
CAM
Connacht Asset Management
New York
-$794K
Name Holding Trade Value Shares
Change 		Change in
Stake
AB
101
Amalgamated Bank
New York
$70K -$2.07K -315 -3%
CG
102
Cutler Group
California
$58K +$58.9K +8,946 New
PA
103
Parallel Advisors
California
$45K – – –
AIP
104
Ameritas Investment Partners
Nebraska
$40K – – –
Canada Life
105
Canada Life
Manitoba, Canada
$35K – – –
QT
106
Quantbot Technologies
New York
$20K +$20.8K +3,168 New
Walleye Trading
107
Walleye Trading
New York
$14K +$14.5K +2,197 New
BA
108
Bellwether Advisors
Nebraska
$13K – – –
BG
109
Bollard Group
Massachusetts
$13K – – –
CAPTRUST Financial Advisors
110
CAPTRUST Financial Advisors
North Carolina
$7K -$20.5K -3,110 -74%
APA
111
American Portfolios Advisors
New York
$3.63K -$5.26K -800 -59%
SSB
112
Sandy Spring Bank
Maryland
$3K -$1.32K -200 -29%
JCM
113
Jacobi Capital Management
Pennsylvania
$3K +$2.63K +400 New
RE
114
RBC Europe
United Kingdom
$1.13K – – –
OSAM
115
O'Shaughnessy Asset Management
Connecticut
$1K – – –
Nisa Investment Advisors
116
Nisa Investment Advisors
Missouri
$9 – – –
CS
117
Candriam SCA
Luxembourg
– -$1.07M -173,646 Closed
HSA
118
Hussman Strategic Advisors
Maryland
– -$887K -144,000 Closed
Jennison Associates
119
Jennison Associates
New York
– -$830K -134,757 Closed
CSS
120
Cubist Systematic Strategies
Connecticut
– -$403K -65,491 Closed
EGM
121
Engineers Gate Manager
New York
– -$186K -30,208 Closed
ProShare Advisors
122
ProShare Advisors
Maryland
– -$120K -19,453 Closed
Victory Capital Management
123
Victory Capital Management
Texas
– -$63K -10,159 Closed
PAM
124
Panagora Asset Management
Massachusetts
– -$28K -4,481 Closed
PCM
125
Pinz Capital Management
New York
– -$24K -3,900 Closed
2 3 4
5
6

LAB Hedge Fund Activity: Q3 2021 in Review

119 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2021, worth a combined $387M — up 9.1% from $354M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new LAB positions and 12 closed out — a net gain of 7 holders — while 32 added to existing stakes and 39 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $2.63M. The largest seller was Millennium Management, cutting an estimated $3.49M.

  • 119 institutional investors held Standard BioTools (LAB) as of Q3 2021, up from 113 in Q2 2021.
  • Funds reported $387M of Standard BioTools stock for Q3 2021, up 9.1% quarter-over-quarter.
  • 19 funds opened new Standard BioTools positions in Q3 2021 and 12 closed out, a net change of +7 holders.
  • The largest Standard BioTools buyer in Q3 2021 was Adage Capital Partners, an estimated $2.63M added.
  • The largest Standard BioTools seller in Q3 2021 was Millennium Management, an estimated $3.49M sold.

Based on aggregated 13F filings for Q3 2021.